Presented by: Olivia Hiskey, PharmD
When & Where
Tuesday, January 16, 2024
6:00 – 7:00pm
Spokane Public Library – Central
Events Room B
906 W. Main Ave.
Register
Dinner will be provided.
CE Information
Activity Type: Knowledge
Target audience: Pharmacists and Pharmacist Technicians
CEUs: 0.1
ACPE UAN: 0130-9999-24-090-L01-P, 0130-9999-24-090-L01-T
Learning Objectives:
At the completion of this activity, the participant will be able to:
1. Identify risk factors for developing atherosclerotic cardiovascular disease (ASCVD)
2. Describe the risks associated with aspirin therapy
3. Recall current guideline recommendations regarding aspirin use in primary and secondary ASCVD prevention
4. Describe the recent data impacting recommendations for aspirin use in primary ASCVD prevention
5. Identify co-morbid conditions and medications that should be considered when determining appropriateness of aspirin therapy for primary and secondary ASCVD prevention
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To Earn CE Credit:
To receive credit, you must be a SPA member and complete the evaluation as validation of attending. The evaluation as well as your NABP e-profile ID and birth date MMDD will need to be received by the WSPA in order for you to receive credit.
The Washington State Pharmacy Association only has 60 days from the date of the activity to upload the CPE information to the CPE Monitor. WSPA will upload the CE within 3-4 weeks after the event. It will be your responsibility to check the CPE Monitor before the 60 days to make sure the CE is uploaded in your profile. If there are any problems, you will need to contact WSPA at 425-228-7171. CE cannot be uploaded after the 60 days from the date of the event.
Spokane Pharmacy Association 